An inconsistent boom-and-bust cycle funding environment for early-stage biotech innovations and burdensome regulation ...
The opening session sets the context and intent for the Inaugural Summit: USA-Saudi Biotech Alliance, outlining the strategic ...
Senior director of R&D at Cargill, Paula Garcia, shares insights from the company’s European R&D Center on how fermentation ...
From the fishing vessels that land wild-caught fish to the salmon farms along the West Coast, the impact of Scotland’s ...
Disciplined pricing, capital constraints, active M&A and adaptive regulation is setting the stage for compelling investment ...
From January 12 to 15, 2026, the 44th J.P. Morgan Healthcare Conference (JPMHC) was held in San Francisco, California, USA. Dr. Ge Michael, President and CEO of Sichuan Kelun-Biotech Biopharmaceutical ...
French biotech recognized among top 1% worldwide for sustainability, reflecting excellence in ESG performance and ...
The Association for Accessible Medicines, which represents generic drugmakers, is expanding its roster of hired guns.
BHUBANESWAR: In a major push to accelerate bio-industrialisation, the state government has announced a comprehensive ...
Vietnam Investment Review on MSN
Kelun Biotech presents strategy at JPM conference
From January 12 to 15, 2026, the 44th J.P. Morgan Healthcare Conference (JPMHC) was held in San Francisco, California, USA.
Acadia Pharma’s Catherine Owen Adams has formed a group of small- to mid-cap biotechs to advocate against a ‘peanut butter ...
International pharmaceutical leaders and investors gathered in San Francisco on Sunday to explore partnership opportunities ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback